Prof. Dr. Bala Başak Öven

  • Uzmanlık Alanları: Genel Onkoloji, Meme Kanseri, Akciğer Kanseri, Mide Kanseri, Kolon Kanseri

Eğitim ve Uzmanlık
2000 - İstanbul Üniversitesi Cerrahpaşa Tıp Fakültesi (İng)     
2006 - İç Hastalıkları    Haydarpaşa Numune Eğitim ve Araştırma Hastanesi - Doktora/S.Yeterlik/ Tıpta Uzmanlık          
2011 - Tıbbi Onkoloji    Dr. Lütfi Kırdar Kartal Eğitim ve Araştırma Hastanesi - Yan Dal Uzmanlık

Deneyim
2001 - 2006 - Haydarpaşa Numune Eğitim ve Araştırma Hastanesi, İç Hastalıkları Bölümü    
2007 - 2008 - Validebağ Devlet Hastanesi, İç Hastalıkları Bölümü    
2008 - 2011 - Dr. Lütfi Kırdar Eğitim ve Araştırma Hastanesi, Tıbbi Onkoloji Bölümü    
2011 - 2012 - Eskişehir Yunus Emre Devlet Hastanesi, Tıbbi Onkoloji Bölümü    
2012 - 2018 - Haydarpaşa Numune Eğitim ve Araştırma Hastanesi, Tıbbi Onkoloji

Kurs ve Sertifikalar
Accademia Oncologica, Breast Cancer Course, Università Vita-Salute San Raffaele Hospital, 4-5 April, 2011, Milano, Italy. Danışmanlar: Prof.Dr. Luca Gianni ve Prof.Dr.Haluk Onat.
Accademia Oncologica, Gastrointestinal Cancer Course, Ospedale San Martino Hospital, 16-17 September, 2011, Genoa, Italy. Danışmanlar: Prof.Dr. Alberto Sobrero ve Prof.Dr.Gökhan Demir.
Anti-angiogenic Approach to Cancer Treatment Preceptorship Program, David Geffen School of Medicine at UCLA,, 28 October-02 November, 2010, Los Angeles, USA. Danışman: Prof. Dr. Fairoz Kabinavar.

Mesleki Üyelikler
European Society of Medical Oncology (ESMO)
Tıbbi Onkoloji Derneği
Anadolu Tıbbi Onkoloji Derneği
Türk Toraks Derneği

Ödüller
5. Ulusal Tıbbi Onkoloji Kongresi En iyi Bildiri Ödülü (2008)
Yılın Yan Dal Araştırma Görevlisi (2009)
6.Ulusal Tıbbi Onkoloji Kongresi En iyi Sözel Bildiri Ödülü (2009)
6.Ulusal Tıbbi Onkoloji Kongresi En İyi Bildiri Ödülü (2009)
6.Ulusal Tıbbi Onkoloji Kongresi En İyi Sözel Bildiri Ödülü (2009)
3. Tıbbi Onkoloji Kongresi, En iyi Sözlü Sunum Becerisi Ödülü (2010).

  1. Uluslararası hakemli dergilerde yayımlanan makaleler :

A1. A. Bilici, E. Karci, E. Altun, S.K. Ozkara, K. Uygun, G. Aksu, B.B. Ustaalioglu, "An unusual case of recurrent endometrial cancer presented with isolated cervical lymph node metastasis",  Arch Gynecol Obstet, 280, 153-156. (2009).

A2. B.B. Ustaalioglu, A. Bilici, M. Seker, T. Salepci, S. Keser, M. Gumus, "Renal cell carcinoma with pulmonary metastasis misdiagnosed as other primary malignant tumor", J BUON, 14, 727-728, (2009).

A3. M. Seker, B.B. Ustaalioglu, A. Bilici, N.I. Ozseker, A. Aksu, M. Gumus, "Acute renal failure and multiple extranodal involvement in a patient with diffuse large B cell lymphoma", J BUON, 14,  726-7, (2009).

A4. B.B. Ustaalioglu, A. Bilici, M. Seker, T. Salman, M. Gumus, N.O. Barisik, T. Salepci, M. Yaylaci, "Metastasis of Lobular Breast Carcinoma to the Uterus in a Patient under Anastrozole Therapy", Onkologie, 32,  424-426, (2009).

A5. B.B. Ustaalioglu, A. Bilici, M. Seker, M. Gumus, N. Ozdemir, T. Salman, M. Yaylaci, "Bilateral primary small lymphocytic lymphoma of the lacrimal sac and review of the literature", Leuk Res, 33, e184-185, (2009).

A6. M. Seker, A. Bilici, B.O. Ustaalioglu, T. Salman, B. Sonmez, N.A. Canpolat, T. Salepci, M. Gumus, M. Yaylaci, "Extended rituximab schedules may result in increased efficacy in pulmonary malt lymphoma", Leuk Res, 33, e154-156, (2009).

A7. M. Kocak, A. Ozkan, A. Mayadagli, C. Parlak, A. Bilici, M. Seker, B.B. Oven Ustaalioglu, M. Gumus, M. Eren, S.G. Karabulut, F. Oruc, "Induction chemotherapy and chemoradiation therapy for inoperable locally advanced non-small-cell lung cancer: a single-institution review of two different regimens", Clin Lung Cancer,  10, 124-129, (2009).

A8. A. Bilici, M. Seker, B.B. Ustaalioglu, T. Salman, A.A. Igdem, E. Celik, T. Salepci, M. Gumus, M. Yaylaci, "Metastatic renal hemangiopericytoma: a rare case report", Arch Oncol, 17, 32-35, (2009).

A9. M Seker, H.I. Gozu, B.B. Oven Ustaalioglu, B. Sonmez, F.Y. Erkal, M. Kocak, N.O. Barisik, E. Orbay, M. Sargin, H. Sargin, U.T. Boru, M. Yaylaci, "Myasthenia gravis and autoimmune Addison disease in a patient with thymoma", Clin Lung Cancer, 10, 367-370, (2009).

A10. B.B. Oven Ustaalioglu, A. Bilici, U. Kefeli, M. Seker, E. Yildirim, T. Salepci, M. Oncel, M. Kement, M. Gumus, "Does the metastatic lymph node ratio ınfluence the disease-free survival of patients with breast cancer: single-center experiences", Oncology, 79, 105–111, (2010), doi: 10.1159/000320162.

A11. A. Bilici, K. Uygun, M. Seker, B.B. Ustaalioglu, M. Aliustaoglu, S. Temiz, G. Aksu, C. Gezen, D. Yavuzer, S. Kaya, T. Salepci, A. Mayadagli, M. Gumus, "The effect of tumor size on overall survival in patients with pT3 gastric cancer: experiences from 3 centers", Onkologie, 33, 676-682 (2010), doi: 10.1159/000322215.

A12. B.B. Ustaalioglu, M. Gumus, A. Unal, K. Cayir, O. Sever, A. Bilici, E.T. Elkiran, H. Karaca, M. Benekli, A. Karaoglu, M. Seker, " Malignancies diagnosed during pregnancy and treated with chemotherapy or other modalities (review of 27 cases): multicenter experiences", Int J Gynecol Cancer, 20, 698-703, (2010), doi: 10.1111/IGC.0b013e3181daaf3e.

A13. A. Bilici, T. Salepci,  F. Dane,  M. Gumus, B.B. Ustaalioglu, M. Seker, T. Salman, C. Turan, O. Unal, M. Yaylaci, "Neoadjuvant chemotherapy followed by interval cytoreductive surgery in patients with unresectable, advanced stage epithelial ovarian cancer: a single centre experience", Arch Gynecol Obstet, 282, 417-425, (2010), doi: 10.1007/s00404-009-1330-7.

A14. A. Bilici, M. Seker, B.B. Ustaalioglu, U. Kefeli, E. Yildirim, D. Yavuzer, F.M. Aydin, T. Salepci, M. Oncel, M. Gumus, "Prognostic significance of perineural invasion in patients with gastric cancer who underwent curative resection", Ann Surg Oncol, 17, 2037-2044, (2010), doi: 10.1245/s10434-010-1027-y.

A15. B.B. Oven Ustaalioglu, M. Gumus, A. Bilici, M. Seker, R. Ustaalioglu, U. Kefeli, T. Salepci, N. Canpolat, A. Mayadagli, I. Dogusoy, "Is there a cut-off value for standardized uptake values in positron emission tomography for predicting response to treatment and survival in patients with advanced non-small cell lung cancer? Single center experience", J BUON, 15, 529-536, (2010).

A16. A. Bilici, B.B. Ustaalioglu, M. Seker, N. Canpolat, B. Tekinsoy, T. Salepci, M. Gumus, "Clinical value of FDG PET/CT in the diagnosis of suspected recurrent ovarian cancer: is there an impact of FDG PET/CT on patient management?", Eur J Nucl Med Mol Imaging, 37, 1259-1269, (2010), doi: 10.1007/s00259-010-1416-2.

A17. A. Bilici, B.B. Ustaalioglu, M. Gumus, M. Seker, B. Yilmaz, U. Kefeli, E. Yildirim, B. Sonmez, T. Salepci, M. Kement, A. Mayadagli, "Is metastatic lymph node ratio superior to the number of metastatic lymph nodes to assess outcome and survival of gastric cancer?", Onkologie, 33, 101–105, (2010), doi: 10.1159/000277927.

A18. A. Bilici, M. Seker, B.B. Ustaalioglu, B. Yilmaz, A. Doventas, T. Salepci, M. Gumus, "Determining of metastatic lymph node ratio in patients who underwent D2 dissection for gastric cancer", Med Oncol, 27, 975-984, (2010), doi: 10.1007/s12032-009-9319-4.

A19. M. Gumus, B.O. Ustaalioglu, M. Garip, E. Kiziltan, A. Bilici, M. Seker, B. Erkol, T. Salepci, A. Mayadagli, N.S. Turhal, "Factors that affect patients’ decision-making about mastectomy or breast conserving surgery, and the psychological effect of this choice on breast cancer patients", Breast Care (Basel), 5, 164-168, (2010), doi: 10.1159/000314266.

A20. M. Aliustaoglu, A. Bilici, M. Seker, F. Dane, M. Gocun, V. Konya, B.B. Ustaalioglu, M. Gumus, "The association of pre-treatment peripheral blood markers with survival in patients with pancreatic cancer", Hepatogastroenterology, 57, 640-645, (2010).

A21. T. Salman, M. Seker, A. Bilici, B.B. Oven Ustaalioglu, M. Gumus, M. Yaylaci, "Lung cancer presenting with extreme leukocytosis", J BUON, 15, 193, (2010).

A22. M. Seker, B.B. Ustaalioglu, A. Bilici, ME. Yildirim, U. Kefeli, N.O. Barisik, I. Tamer, M. Gumus, "Eight-cycle rituximab therapy resulted in complete remission in primary cutaneous marginal zone lymphoma", Leuk Res, 34, e160-163, (2010), doi: 10.1016/j.leukres.2010.02.013.

A23. A. Bilici, B.B. Ustaalioglu, M. Seker, N. Canpolat, M. Gumus, "F-18 FDG PET/CT imaging in recurrent mantle cell lymphoma presenting with cauda equina syndrome", Clin Nucl Med, 35, 211-212, (2010).

A24. A. Bilici, B.B. Ustaalioglu, M. Seker, S. Kayahan, "Case report: soft tissue metastasis from immature teratoma of the testis: second case report and review of the literature", Clin Orthop Relat Res, 468, 2541-2544, (2010), doi: 10.1007/s11999-009-1173-3.

A25. M. Seker, A. Bilici, B. Sonmez, B.B. Ustaalioglu, M. Gumus, H. Gozu, M. Sargin, A. Orcun, C. Gezen, M. Eser, N. Bildik, T. Salepci, "The association of serum adiponectin levels with histopathological variables in gastric cancer patients", Med Oncol, 27, 1319-1323, (2010), doi: 10.1007/s12032-009-9382-x.

 

A26. M. Aliustaoglu, A. Bilici, B.B. Ustaalioglu, V. Konya, M. Gucun, M. Seker, M. Gumus, "The effect of peripheral blood values on prognosis of patients with locally advanced gastric cancer before treatment", Med Oncol, 27, 1060-1065, (2010), doi: 10.1007/s12032-009-9335-4.

A27. B.B. Ustaalioglu, A. Bilici, M. Seker, N. Canpolat, N. Ozdemir, T. Salepci, M. Gumus, "Primary non-Hodgkin lymphoma of cervix successfully treated with rituximab: Positron emission tomography images before and after therapy: A case report", Leuk Res, 34, e108-110, (2010), doi: 10.1016/j.leukres.2009.10.020.

 

A28. M. Aliustaoglu, A. Bilici, M. Gumus, A.T. Colak, G. Baloglu, R. Irmak, M. Seker, BB. Ustaalioglu, T. Salman, B. Sonmez, T. Salepci, M. Yaylaci, "Preoperative serum leptin levels in patients with breast cancer", Med Oncol, 27, 388-391, (2010), doi: 10.1007/s12032-009-9222-z.

A29. T. Salepci, M. Seker, H. Uyarel, M. Gumus, A. Bilici, B.B. Ustaalioglu, A. Ozturk, B. Sonmez, A. Orcun, M. Ozates, R. Irmak, M. Yaylaci, "5-Fluorouracil induces arterial vasoconstrictions but does not increase angiotensin II levels", Med Oncol, 27, 416-420, (2010), doi: 10.1007/s12032-009-9226-8.

A30. A.O. Kaya, S. Buyukberber, F. Dane, A. Isıkdogan, B.O. Ustaalioglu, U. Coskun, P.F. Yumuk, C.G. Dogu, N.Y. Ozdemir, A. Sevinc, M. Gumus, M. Ozkan, R. Yildiz, B. Ozturk, E. Yaman, M. Benekli, "Cisplatin plus docetaxel combination in the first-line treatment of metastatic non-small cell lung cancer", Tumori, 96, 400-404, (2010).

A31. M. Seker, B. Ozdemir, A. Bilici, B.B. Ustaalioglu, B. Sonmez, B.E. Yilmaz, E. Kurnaz, M. Gumus, M. Yaylaci, "Bilateral conjunctival MALT lymphoma mimicking chronic conjunctivitis", Onkologie, 33, 317-320, (2010).

A32. B.B. Ustaalioglu, M. Gumus, A. Bilici, M. Seker, F. Dane, T. Salepci, T. Salman, M. Aliustaoglu, M. Eser, C. Gezen, M. Yaylaci, N.S. Turhal, "Neoadjuvant chemotherapy for locally advanced breast cancer: a single center experience", Med Oncol, 27, 454-458, (2010), doi: 10.1007/s12032-009-9233-9.

A33. B.B. Ustaalioglu, A. Bilici, U. Kefeli, M. Seker, M. Oncel, C. Gezen, M. Gumus, F. Demirelli, "The importance of multifocal/multicentric tumor on the disease-free survival of breast cancer patients: single center experience", Am J Clin Oncol, (2011), doi: 10.1097/COC.0b013e31822d9cd6.

A34. B.B. Ustaalioglu, A. Bilici, U. Kefeli, M. Seker, T. Salepci, O. Unal, M. Gumus, "A retrospective analysis of women’s chances to become pregnant after completion of chemotherapy: a single center experience", J BUON, 16, 349-352, (2011).

A35. B.B. Ustaalioglu, M. Seker, A. Bilici, N. Canpolat, E. Yildirim, U. Kefeli, R. Ustaalioglu, B.E. Yilmaz, T. Salepci, N. Ozdemir, M. Gumus, "The role of PET-CT in the differential diagnosis of thymic mass after treatment of patients with lymphoma", Med Oncol,  28, 258-264, (2011), doi: 10.1007/s12032-010-9446-y.

A36. B.B. Oven Ustaalioglu, U. Kefeli, A. Bilici, R. Ustaalioglu, M. Seker, F. Cinarel, I. Dogusoy, "F-18 FDG PET/CT imaging and bronchoscopic image of tracheal recurrence in patient with non-small-cell lung cancer", Clin Nucl Med, 36, 367-369, (2011).

A37. A. Bilici, F. Dane, M. Seker, B.B. Ustaalioglu, M. Aliustaoglu, S. Temiz, C. Gezen, D. Yavuzer, G. Aksu, A. Mayadagli, M. Gumus, K. Uygun, N.S. Turhal,  "Is subdivision of pT2 tumors superior to lymph node metastasis for predicting survival of patients with gastric cancer? review of 224 patients from four centers", Dig Dis Sci, (2011), doi: 10.1007/s10620-011-1721-z.

A38. A. Bilici, B.B. Ustaalioglu, M. Seker, U. Kefeli, N. Canpolat, B. Tekinsoy, S. Ozogur, M. Gumus, "The role of (18)F-FDG PET/CT in the assessment of suspected recurrent gastric cancer after initial surgical resection: can the results of FDG PET/CT influence patients' treatment decision making?", Eur J Nucl Med Mol Imaging, 38, 64-73, (2011), doi: 10.1007/s00259-010-1611-1.

A39. O. Kanat, S. Kilicalp, T. Korkmaz, B.B. Oven Ustaalioglu, M. Canhoroz, E. Cubukcu, S. Tolunay, T. Evrensel, O. Manavoglu, "Primary small cell carcinoma of the breast: report of seven cases and review of the literature", Tumori, 97, 473-478, (2011), doi: 10.1700/950.10400.

A40. B. Budakoğlu, S. Aksoy, C. Arslan, U. Uyeturk, N.A. Babacan, M.F. Ozcan, R. Yıldız, B.B.Oven, N.Y. Ozdemir, O. Dizdar, S. Buyukberber, M.B. Akıncı, I. Turker, B. Oksuzoğlu, K. Altundag, N. Zengin, “Frequency of HCV infection in renal cell carcinoma patients”, Med Oncol, (2011), doi:10.1007/s12032-011-9928-6.

A41. M. Seker, A. Bilici, D.O. Guler, B.B. Ustaalioglu, H. Gozu, F.Y. Erkal, B. Sonmez, M. Karaduman, U. Kefeli, E. Yildirim, T. Salepci, M. Gumus, "Tissue and serum adiponectin levels in patients with gastric cancer: Are there any correlations between adiponectin levels and histopathological variables?", Hepatogastroenterology, 58, 110-111, (2011), doi: 10.5754/hge10288.

A42. B. Sonmez, M. Seker, A. Bilici, F.Y. Erkal, B.B. Oven Ustaalioglu, M. Gumus, D. Ozturk Guler, M. Karaduman, C. Gezen, M. Eser, N. Bildik, T. Salepci, "Is there any correlation among adiponectin levels in serum, tumor tissue and normal tissue of the same patients with breast cancer?", J BUON, 16, 227-232, (2011).

A43. A. Bilici, B.B. Ustaalioglu, S. Ercan, A. Orcun, M. Seker, T. Salepci, M. Gumus, "Is there any impact of plasma M30 and M65 levels on progression-free survival of patients with advanced gastric cancer?", Cancer Chemother Pharmacol, 68, 309–316, (2011), doi:10.1007/s00280-010-1480-0.

A44. A. Sevinc, M. Seker, A. Bilici, N.Y. Ozdemir, R. Yildiz, B.O. Ustaalioglu, M.E. Kalender, F. Dane, H. Karaca, C. Gemici, M. Gumus, S. Buyukberber, "Co-existence of gastrointestinal stromal tumors with other primary neoplasms", Hepatogastroenterology, 58, 824-830, (2011).

A45. A. Bilici, M. Seker, B.B. Ustaalioglu, N. Canpolat, T. Salepci, M. Gumus, "Pulmonary BALT lymphoma successfully treated with eight cycles weekly rituximab: report of first case and F-18 FDG PET/CT images", J Korean Med Sci, 26, 574-576, (2011), doi: 10.3346/jkms.2011.26.4.574.

A46. M. Seker, A. Bilici, B.O. Ustaalioglu, B. Yilmaz, B. Ozturk, A. Unal, F. Dane, N.Y. Ozdemir, E.T. Elkiran, ME. Kalender, M. Gumus, M. Benekli, "Clinicopathologic features of the nine patients with primary diffuse large B cell lymphoma of the breast", Arch Gynecol Obstet, 284, 405-409, (2011), doi: 10.1007/s00404-010-1683-y.

A47. U. Kefeli, S. Kaya, B.O. Ustaalioglu, A. Bilici, A.U. Kefeli, M.E. Yildirim, M. Seker, B. Yilmaz, T. Salepci, K. Uygun, M. Gumus, "Prognostic factors in elderly patients with non-small cell lung cancer: a two-center experience", Med Oncol, 28, 661-666, (2011), doi: 10.1007/s12032-010-9504-5.

A48. U. Kefeli, A. Bilici, B.B. Ustaalioglu, A.U. Kefeli, M.E. Yildirim, M. Seker, M. Gumus, "A case of metastatic breast cancer successfully treated with lapatinib plus capecitabine therapy", Arch Gynecol Obstet, 283, 405-407, (2011), doi: 10.1007/s00404-010-1519-9.

A49. Oven Ustaalioglu BB1Bilici AKefeli USeker MSalepci TUnal OGumus M  A retrospective analysis of women's chances to become pregnant after completion of chemotherapy: a single center experience. J BUON. 2011 Apr-Jun;16(2):349-52.

 

DOÇENTLİK SONRASI:

A50. Bilici A, Ustaalioglu BB, Yavuzer D, Seker M, Mayadagli A, Gumus M. ‘’Prognostic significance of high phosphatase of regenerating liver-3 expression in patients with gastric cancer who underwent curative gastrectomy.’’ Dig Dis Sci, Jun;57(6):1568-75. doi: 10.1007/s10620-012-2076-9. Epub 2012 Feb 14, (2012).

A51. Bilici A, Yapici HS, Ercan S, Seker M, Ustaalioglu BB, Salman T, Orcun A, Gumus M. ‘’The prevalence and significance of autoantibodies in patients with non-Hodgkin's lymphoma: are they correlated with clinicopathological features?’’ J BUON,  Jul-Sep;17(3):502-7, (2012).

A52. Baykara M, Ozturk SC, Buyukberber S, Helvaci K, Ozdemir N, Alkis N, Berk V, Koca D, Coskun U, Oksuzoglu B, Uncu D, Arpaci E, Ustaalioglu BO, Demirci U, Kucukoner M, Dogu GG, Alici S, Akman T, Ozkan M, Aslan UY, Durnali AG, Benekli M. ‘’Clinicopathological features in bilateral breast cancer.’’ Asian Pac J Cancer Prev. 2012;13(9):4571-5.

A53. Bilici A, Yapici HS, Ercan S, Seker M, Ustaalioglu BB, Salman T, Orcun A, Gumus M. ‘’ The prevalence and significance of autoantibodies in patients with non-Hodgkin's lymphoma: are they correlated with clinicopathological features?’’

J BUON. 2012 Jul-Sep;17(3):502-7.

A54. Altinbas M, Kalender ME, Oven B, Sevinc A, Karaca H, Kaplan MA, Alici S, Arpaci E, Yildiz R, Uncu D, Camci C, Gumus M. ‘’Weekly topotecan for recurrent small cell lung cancer - a retrospective Anatolian Medical Oncology Group study.’’ Asian Pac J Cancer Prev. 2012;13(6):2909-12.

A55. Oven Ustaalioglu B, Ulas A, Esbah O, Turan N, Bilic A, Demirci U, Alkıs N, Seker M, Oksuzoglu B, Gumus M, ASMO (Anatolian Society of Medical Oncology) Large cell neuroendocrine carcinoma:retrospective analysis of 24 cases from four oncology centers in Turkey. Thoracic Cancer 2012 doi.10.1111/j.1759-7714.2012.00129x

A56. Oven Ustaalioglu B, Bilici A, Ercan S, Orcun A, Seker M, Ozkan A, Ustaalioglu R, Gumus M. ‘’Serum M30 and M65 values in patients with advanced stage non-small-cell lung cancer compared with controls.’’ Clin Transl Oncol. 2012 May;14(5):356-61. doi: 10.1007/s12094-012-0808-0.

A57. Ustaalioglu BB, Bilici A, Barisik NO, Aliustaoglu M, Vardar FA, Yilmaz BE, Seker M, Gumus M. ‘’Clinical importance of phosphatase of regenerating liver-3 expression in breast cancer.’’ Clin Transl Oncol. Dec;14(12):911-22. doi: 10.1007/s12094-012-0880-5. Epub 2012 Jul 19, (2012)

A58. Bilici A, Ustaalioglu BB, Ercan S, Seker M, Yilmaz BE, Orcun A, Gumus M. ‘’The prognostic significance of the increase in the serum M30 and M65 values after chemotherapy and relationship between these values and clinicopathological factors in patients with advanced gastric cancer.’’ Tumour Biol. Dec;33(6):2201-8. doi: 10.1007/s13277-012-0481-5. Epub 2012 Aug 14, (2012).

A59. Bilici A, Ustaalioglu BB, Yavuzer D, Seker M, Mayadagli A, Gumus M. ‘’Prognostic significance of high phosphatase of regenerating liver-3 expression in patients with gastric cancer who underwent curative gastrectomy.’’ Dig Dis Sci. Jun;57(6):1568-75. doi: 10.1007/s10620-012-2076-9. Epub 2012 Feb 14, (2012).

A60. Ustaalioglu BB, Bilici A, Barisik NO, Aliustaoglu M, Vardar FA, Yilmaz BE, Seker M, Gumus M. ‘’Clinical importance of phosphatase of regenerating liver-3 expression in breast cancer.’’ Clin Transl Oncol. Dec;14(12):911-22. doi: 10.1007/s12094-012-0880-5. Epub 2012 Jul 19, (2012).

A61. Ustaalioglu BB, Bilici A, Ercan S, Seker M, Orcun A, Gumus M. ‘’The prognostic importance of changing serum M30 and M65 values after chemotherapy in patients with advanced-stage non-small-cell lung cancer’’ Med Oncol. Jun;30(2):551. doi: 10.1007/s12032-013-0551-6. Epub 2013 Mar 28, (2013).

A62. Oven Ustaalioglu BB, Unal OU, Turan N, Bilici A, Kaya S, Eren T, Ulas A, Inal A, Berk V, Demirci U, Alici S, Bal O, Benekli M, Gumus M. ‘’Prognostic factors for lymph node negative stage I and IIA non-small cell lung cancer: multicenter experiences.’’ Asian Pac J Cancer Prev, 14(11):6287-92, (2013).

A63. Bilici A, Salman T, Oven Ustaalioglu BB, Unek T, Seker M, Aliustaoglu M, Gezen C, Unek T, Yavuzer D, Unlu M, Gumus M, Yilmaz U. ‘’The prognostic value of detecting symptomatic or asymptomatic recurrence in patients with gastric cancer after a curative gastrectomy.’’ J Surg Res. 2013 Mar;180(1):e1-9. doi: 10.1016/j.jss.2012.03.035. Epub 2012 Apr 11.

A64. Turan N, Benekli M, Koca D, Ustaalioglu BO, Dane F, Ozdemir N, Ulas A, Oztop I, Gumus M, Ozturk MA, Berk V, Kucukoner M, Uner A, Balakan O, Helvaci K, Ozkan S, Yilmaz U, Buyukberber S; Anatolian Society of Medical Oncology. ‘’Adjuvant systemic chemotherapy with or without bevacizumab in patients with resected liver metastases from colorectal cancer.’’ Oncology, 84(1):14-21. doi: 10.1159/000342429. Epub 2012 Oct 16, (2013).

A65. Uygun K, Bilici A, Kaya S, Oven Ustaalioglu BB, Yildiz R, Temiz S, Seker M, Aksu G, Cabuk D, Gumus M. ‘’XELIRI plus bevacizumab compared with FOLFIRI plus bevacizumab as first-line setting in patients with metastatic colorectal cancer: experiences at two-institutions.’’ Asian Pac J Cancer Prev. , 14(4):2283-8, (2013).

A66. Korkmaz T, Seber S, Kefeli U, Sari E, Canhoroz M, Oven B, Yildirim E, Yasar N, Aydin D, Balvan O, Sener N, Yuksel S, Mert A, Polat O, Yumuk F, Kanat O, Gumus M, Turhal NS. ‘’Comparison of second-line treatment outcomes between sensitive and refractory small cell lung cancer patients: a retrospective analysis.’’ Clin Transl Oncol. 2013 Jul;15(7):535-40. doi: 10.1007/s12094-012-0960-6. Epub 2012 Nov 10

A67. Bılıcı A, Şeker M, Öven Ustaalıoğlu BB, Keser SH, Cınaral F, Gümüş M. ‘’Gallbladder metastasis secondary to gastric cancer as a first site of recurrence presented with acute cholecystitis: case report and literature review.’’ Turk J Gastroenterol. 2012;23(6):764-8. Review J Surg Res. 2013 Mar;180(1):e1-9. doi: 10.1016/j.jss.2012.03.035. Epub 2012 Apr 11.

A68. Bilici A, Selcukbiricik F, Demir N, Oven Ustaalioglu BB, Dikilitas M, Yildiz O. Modified docetaxel and cisplatin in combination with capecitabine (DCX) as a first-line treatment in HER2-negative advanced gastric cancer. Asian Pac J Cancer Prev.,15(20):8661-6, (2014).

A69. Bilici A, Inanc M, Ulas A, Akman T, Seker M, Babacan NA, Inal A, Bal O, Koral L, Sevinc A, Tufan G, Elkiran ET, Ustaalioglu BB, Yavuzsen T, Alkis N, Ozkan M, Gumus M. ‘’Clinical and pathologic features of patients with rare ovarian tumors: multi-center review of 167 patients by the anatolian society of medical oncology.’’ Asian Pac J Cancer Prev, Jan;14(11):6493-9, (2014).

A70. Ustaalioglu BO, Aker Vardar F, Bilici A, Gurleyik G, Erkol B, Kefeli U, Aliustaoglu M. ‘’Clinical importance of discordance of hormone receptors and Her2/neu status after neoadjuvant chemotherapy in breast cancer.’’ J BUON. Oct-Dec;19(4):879-86, (2014)

A71. Oven Ustaalioglu BB, Bilici A, Yilmaz BE, Aliustaoglu M, Seker M, Vardar F, Gumus M. ‘’Important Factors Affecting Adjuvant Treatment Decision in Stage IA Breast Cancer Patients in Turkey.’’ Breast Care (Basel). May;9(2):123-7. doi: 10.1159/000360929, (2014)

A72. Bilici A, Sonkaya A, Ercan S, Ustaalioglu BB, Seker M, Aliustaoglu M, Orcun A, Gumus M. The changing of serum vitamin B12 and homocysteine levels after gastrectomy in patients with gastric cancer: do they associate with clinicopathological factors? Tumour Biol. Feb;36(2):823-8. doi: 10.1007/s13277-014-2705-3. Epub 2014 Oct 9, (2015).

A73. Turan N, Benekli M, Unal OU, Unek İT, Tastekin D, Dane F, Algın E, Ulger S, Eren T, Topcu TO, Turkmen E, Babacan NA, Tufan G, Urakci Z, Ustaalioglu BO, Uysal OS, Ercelep OB, Taskoylu BY, Aksoy A, Canhoroz M, Demirci U, Dogan E, Berk V, Balakan O, Ekinci AŞ, Uysal M, Petekkaya İ, Ozturk SC, Tonyalı Ö, Çetin B, Aldemir MN, Helvacı K, Ozdemir N, Oztop İ, Coskun U, Uner A, Ozet A, Buyukberber S; Anatolian Society of Medical Oncology (ASMO). Impact of adjuvant treatment modalities on survival outcomes in curatively resected pancreatic and periampullary adenocarcinoma. Chin J Cancer Res. 2015 Aug;27(4):408-16. doi: 10.3978/j.issn.1000-9604.2015.08.03.

A74. Öven Ustaalioğlu BB, Tilki M, Kılıçoğlu ZG, A,Bilici Sürmelioğlu A, Ustaalioğlu R, Erkol B.  Prognostic markers for metastatic colon cancer patients undergoing multiple metastasectomies. Turk J Gastroenterol. 2015 Sep;26(5):386-91. doi: 10.5152/tjg.2015.0169. Epub 2015 Jul 24.

A75. Oven Ustaalioglu BB, Balvan O, Bilici A, Develi A, Aliustaoglu M, Vardar FA, Erkol B.  The differences of clinicopathological factors for breast cancer in respect to time of recurrence and effect on recurrence-free survival. Clin Transl Oncol. 2015 Nov;17(11):895-902. doi: 10.1007/s12094-015-1323-x. Epub 2015 Jun 17.

A76. Yildirim M, Ustaalioglu R, Erkan M, Ustaalioglu BB, Demirbag H, Yasaroglu M, Dogusoy I, Okay T. The Diagnostic Value of Pericardial Fluid and Pericardial Biopsy: Single Center Experiences. Heart Surg Forum. 2016 Feb 23;19(1):E023-7. doi: 10.1532/hsf.1328.

A77. Ozcelik M, Odabas H, Ercelep O, Yuksel S, Mert AG, Aydin D, Surmeli H, Isik D, Isik S, Oyman A, Oven Ustaalioglu BB, Aliustaoglu M, Gumus M.  The efficacy and safety of capecitabine plus bevacizumab combination as first-line treatment in elderly metastatic colorectal cancer patients. Clin Transl Oncol. 2016 Jun;18(6):617-24. doi: 10.1007/s12094-015-1408-6. Epub 2015 Oct 12.

A78. Aydin D, Sendur MA, Kefeli U, Unal OU, Tastekin D, Akyol M, Tanrikulu E, Ciltas A, Ustaalioglu BB, Uysal M, Esbag O, Yazilitas D, Tanrıverdi O, Bilici A, Arpaci E, Berk V, Yetisyigit T, Ozdemir NY, Oztop I, Alacacioglu A, Aydin O, Ozcelik M, Yildirim E, Dinc N, Gumus M. Evaluation of Prognostic Factors and Adjuvant Chemotherapy in Patients With Small Bowel Adenocarcinoma Who Underwent Curative Resection. Clin Colorectal Cancer. 2016 Aug 30. pii: S1533-0028(16)30149-9. doi: 10.1016/j.clcc.2016.08.002. [Epub ahead of print]

A79. Gumus M, Bilici A, Odabas H, Ustaalioglu BB, Kandemir N, Demirci U, Cihan S, Bayoglu IV, Ozturk T, Turkmen E, Urakci Z, Seker MM, Gunaydin Y, Selcukbiricik F, Turan N, Sevinc A. Outcomes of surveillance versus adjuvant chemotherapy for patients with stage IA and IB nonseminomatous testicular germ cell tumors. World J Urol. 2016 Nov 3. [Epub ahead of print]

A80. Aydin D, Ali Sendur M, Kefeli U, Umut Unal O, Tastekin D, Akyol M, Tanrikulu E, Ciltas A, Bala Ustaalioglu B, Sener Dede D, Esbag O, Inal A, Bilir C, Bilici A, Harputlu H, Berk V, Sevinc A, Yildirim Ozdemir N, Yildirim E, Sonkaya A, Ali Ustaoglu M, Gumus M. Evaluation of prognostic factors and treatment in advanced small bowel adenocarcinoma: report of a multi-institutional experience of Anatolian Society of Medical Oncology (ASMO). J BUON. 2016 Sept-Oct;21(5):1242-1249.

A81. Aydin D, Sendur MA, Kefeli U, Ustaalioglu BB, Aydin O, Yildirim E, Isik D, Ozcelik M, Surmeli H, Oyman A, Isik S, Sener N, Ercelep O, Odabas H, Aliustaoglu M, Gumus M. Evaluation of Bevacizumab in Advanced Small Bowel Adenocarcinoma. Clin Colorectal Cancer. 2016 May 7. pii: S1533-0028(16)30061-5. doi: 10.1016/j.clcc.2016.04.013. [Epub ahead of print]

A82. Oven Ustaalioglu BB, Ustaalioglu R, Yildirim M. Two Cases of Colon Cancer Patients Who Were Treated with Cetuximab and Presented with Superior Vena Cava Syndrome. American Journal of Medical Case Reports, 2016, Vol. 4, No. 11, 361-363.

A83. Gurleyik G, Karagulle H, Eris E, Aker F, Ustaalioglu BO. Oncoplastic surgery; volume displacement techniques for breast conserving surgery in patients with breast cancer. Acta Chir Belg. 2017 Jan 5:1-7. doi: 10.1080/00015458.2016.1272916

 

A84. Ustaalioğlu BBÖ, Tilki M, Sürmelioğlu A, Bilici A, Gönen C, Ustaalioğlu R, Balvan Ö, Aliustaoğlu M. The clinicopathologic characteristics and prognostic factors of gastroesophageal junction tumors according to Siewert classification. Turk J Surg. 2017 Mar 1;33(1):18-24. doi: 10.5152/UCD.2017.3379. eCollection 2017.

A85. Öven Ustaalioğlu BB, Acar E, Çalışkan M. The predictive factors for perceived social support among cancer patients and caregiver burden of their family caregivers in Turkish population. International journal of psychiatry in clinical practice. Doi:10.1080/13651501.2017.1358370.

  1. Yazılan uluslararası kitaplar veya kitaplarda bölümler :

1.Bala Başak Öven Ustaalioğlu, Onkoloji El Kitabı.Akciğer Kanserleri, 2015, 247-254.

2. Bala Başak Öven Ustaalioğlu, Jinekolojik Tümörleri, Tanı- Tedavi –Takip, 2016.

C. Ulusal hakemli dergilerde yayımlanan makaleler :

C1. E. Şimşek, B. Öven, M.M. Doğan, S. Özkan, M.A. Tarım, R. Demirtunç, "Kutenöz poliarteritis nodasa: vaka sunumu ve literatürün gözden geçirilmesi", Haydarpaşa Numune Eğitim ve Araştırma Tıp Dergisi, 124-126, (2001).

C2. M. Başar, B.B. Öven, E. Şimşek, A. Adik, R. Demirtunç, "Tanınız nedir?", Haydarpaşa Numune Eğitim ve Araştırma Tıp Dergisi, 42,57, (2002).

C3. A. Adik, E. Şimşek, B.B Öven, T. Garip, M. Başar, M. Teomete, R. Demirtunç, "Erişkin Still hastalığı", Haydarpaşa Numune Eğitim ve Araştırma Tıp Dergisi, 44,112-114, (2004).  

C4. B.B.Ö. Ustaalioğlu, M. Şeker, A. Bilici, B. Erkol, U. Kefeli, E. Yıldırım, B. Sönmez,  M. Gümüş, T. Salepçi, "Nadir bir nazolakrimal hemanjioperistom olgusu", Kartal Eğitim ve Araştırma Hastanesi Tıp Dergisi,  19, 93-96, (2008).

C5. B.B.Ö. Ustaalioğlu, A. Bilici, M. Şeker, T. Salepçi, E. Yıldırım, U. Kefeli, M. Kement, M. Gümüş, "İnflamatuar meme kanseri serimiz: tek merkez deneyimi", Acta Oncologica Turcica, 42, 93-99, (2009).

C6. A. Bilici, M. Şeker, B.B.Ö. Ustaalioğlu, F. Dane, M. Aliustaoğlu, B.E. Yılmaz, C. Gezen, T. Salepçi, M. Gümüş, K. Uygun, "Lenf nodu negatif mide kanserli hastalarda sağkalım üzerine etkili prognostik faktörlerin değerlendirilmesi: üç merkez deneyimi", Türk Onkoloji Dergisi, 25, 135-142, (2010).

C7. M. Aliustaoğlu, B.B.Ö. Ustaalioğlu, A. Bilici, V. Konya, M. Gücün, M. Şeker, M. Gümüş, "Is the complete blood count parameters predict prognosis before treatment in metastatic gastric cancer patients?", Acta Oncologica Turcica, 43, 13-18, (2010).

C8. A. Bilici, M. Şeker, B.B.Ö. Ustaalioğlu, T. Salman, T. Salepçi, D. Yavuzer, M. Gümüş, "Anastrazol tedavisi altında izole over metastazı ile saptanan nüks meme kanseri olgusu", Acta Oncologica Turcica, 43, 42-45, (2010).

C9. B.B.O. Ustaalioğlu, R. Ustaalioğlu, A. Bilici, I. Doğusoy, N.Ö. Barışık, M. Gümüş, "Metastasis of renal pelvis carcinoma to the thoracic wall successfully treated with surgery: report of first case", Acta Oncologica Turcica, 44, 36-39, (2011).

C10. M. Şeker, A. Mengi, A. Bilici,  B.B. Ustaalioğlu, U. Kefeli, N.I. Özşeker, A. Mayadağlı, T. Salepçi, M. Gümüş, "Hodgkin lenfoma olgularının retrospektif değerlendirilmesi ve prognostik faktörlerin saptanması", Türk Onkoloji Dergisi, 26, (2011), doi:  10.5505/tjoncol.2011.630.

C11. Öven Ustaalioğlu BB, Bilici A, Şeker M, Salepçi T, Ustaalioğlu R, Cömert S, Mayadağlı A, Gümüş M. ‘’The Relationship between Prognostic Factors and Overall Survival in Small Cell Lung Cancer Patients: a Single Centre Experience’’. Turkish Thoracic Journal, 13:60-64, DOI: 10.5152/ttd.2012.14, (2011).

C12. M. Kement, C. Gezen, A. Aşık, A. Karaöz, B.Ö. Ustaalioğlu, A. Bilici, M. Öncel, "Meme kanserli Türk kadınlarında meme koruyucu cerrahi ve modifiye radikal mastektomi; yaşam kalitesine yönelik ileriye dönük bir analiz", Türkiye Klinikleri Tıp Bilimleri Dergisi (ISI), (2011), doi: 10.5336/medsci.2010-20018.

C13.Bilici A, Öven Ustaalioğlu BB, Şeker M, Gümüş M, Ünal O. ‘’Nadir görülen over tümörlerinde klinikopatolojik özellikler’’. Türk Onkoloji Dergisi, 27(1):1-9 doi: 10.5505/tjoncol.2012.627 (2012).

C14. Bilici A, Şeker M, Öven Ustaalioğlu BB, Keser Halaç S, Cinaral F, Gümüş M. ‘’Gallbladder metastasis secondary to gastric cancer as a first site of recurrence presented with acute cholecystitis: Case report and literature review’’ Turk J Gastroenterol , 23 (6): 764-768 doi: 10.4318/tjg.2012.0439, (2012).

C15. Erkol B, Tilki M, Comunoglu N, Ustaalioglu BBO, Aker F, Sürmelioglu A, Telli F, Gemici C, Kılıçoglu ZG, Yeşil A. Neuroendocrine/squamous gastric collision tumor: A rare entity. Turk J Gastroenterol 2014; 25 (Suppl.-1): 282-3

C16. Avcı N, Ulaş A, Aydın T, Tolunay Ş, Oven Ustaalioğlu BB, Kurt E, Evrensel T. ‘’Metaplastik meme kanseri ve EGFR ekspresyonu’’ J Clin Anal Med, 6(5): 616-9, (2015).

C17. Kefeli U, Ustaalioğlu Oven BB, Yılmaz B, Aydın D, Sener N, Aliustaoğlu M. ‘’Non-small  cell lung cancer in women:a distinct entity?’’ GMJ, 25:92-96 (2015).

C18. Kefeli U, Ustaalioğlu BBO, Yıldırım ME, Erkol B, Aydın D,  Şener N, Sonkaya A, Açıkgöz Ö. Akciğer kanserinde sağkalımı etkileyen klinikopatolojik özellikler. Marmara Medical Journal 2015; 28: 21-26 DOI: 10.5472/MMJ.2015.03829.

C19. Erkol B, Aker F, Kılıçoğlu ZG, Ustaalioğlu B, Salman T. Serum β-human chorionic gonadotropin  as a tumor marker for malignant mesothelioma. Marmara Medical Journal 2016; 29: 127-130 DOI: 10.5472/MMJcr.2902.06.

C20. Başak Bala Öven Ustaalioğlu, Ezgi Acar. The depression and related factors among cancer patients and their family caregivers in Turkish Population.Acta Oncologica Turica, 2017;  :115-123.Doi: 10.5505/aot.2017.81994